首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

CURRENT DRUG TARGETS
ISSN：1389-4501

CURRENT DRUG TARGETS

CURR DRUG TARGETS
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：一般,3-8周
新锐分区：医学4区
年发文量：76
影响因子：2.5
JCR分区：Q3

基本信息

《现代药物靶点》旨在报道分子药物靶点的药物化学和药理学的最新和最突出的发展，例如疾病特异性蛋白质、受体、酶、基因。《现代药物靶点》出版由该领域领导人撰写的客座编辑主题期刊，涵盖一系列现代药物靶点主题。该杂志还接受发表小型和全长综述文章和药物临床试验研究。随着新的人类药物靶点的发现、鉴定、表征和验证的药物发现持续增长;这本杂志是所有参与药物发现和开发的药学科学家必不可少的阅读。
1389-4501SCIE/Scopus收录
2.5
点击查看最新影响趋势>
3.2
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：PHARMACOLOGY & PHARMACY
SCIE
Q3
181/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：PHARMACOLOGY & PHARMACY
SCIE
Q3
261/353
92
76
点击查看年发文量趋势图>
15%较难一般,3-8周-医学-药学
0%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
3.95%2.26%-
CiteScore：7.20
SJR：0.693
SNIP：0.756
学科类别分区排名百分位
大类：Biochemistry, Genetics and Molecular Biology
小类：Clinical Biochemistry
Q1
27 / 121
大类：Biochemistry, Genetics and Molecular Biology
小类：Pharmacology
Q2
82 / 321
大类：Biochemistry, Genetics and Molecular Biology
小类：Drug Discovery
Q2
45 / 156
大类：Biochemistry, Genetics and Molecular Biology
小类：Molecular Medicine
Q2
57 / 177

期刊高被引文献

Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective.
来源期刊：Current drug targetsDOI：10.2174/1389450119666181022153016
CDK9 as an Appealing Target for Therapeutic Interventions.
来源期刊：Current drug targetsDOI：10.2174/1389450119666181026152221
Functional Diversity of Quorum Sensing Receptors in Pathogenic Bacteria: Interspecies, Intraspecies and Interkingdom Level.
来源期刊：Current drug targetsDOI：10.2174/1389450120666181123123333
Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte.
来源期刊：Current drug targetsDOI：10.2174/1389450119666180405094046
Bioinformatics approaches for anti-cancer drug discovery.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190923162203
Opportunities of Bacterial Cellulose to Treat Epithelial Tissues
来源期刊：Current Drug TargetsDOI：10.2174/1389450120666181129092144
Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological Research.
来源期刊：Current drug targetsDOI：10.2174/1389450119666180808105056
Molecular Aspects of Melatonin Treatment in Tinnitus; a Review.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190319162147
Influence of Ultrafine Particles Exposure on Asthma Exacerbation in Children: A Meta-Analysis.
来源期刊：Current drug targetsDOI：10.2174/1389450119666180829114252
Understanding Membrane Protein Drug Targets in Computational Perspective.
来源期刊：Current drug targetsDOI：10.2174/1389450120666181204164721
Toll like receptors as a novel therapeutic target for natural products against chronic diseases.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190222181506
Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory Disorders.
来源期刊：Current drug targetsDOI：10.2174/1389450119666180816121323
Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190821160730
Anti-tumor drug targets analysis: current insight and future prospect.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190402145325
Potential Therapeutic Applications of P2 Receptor Antagonists: from Bench to Clinical Trials.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190213095923
Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 2: Focus on Schizophrenia.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190801114210
PPARγ: Potential therapeutic target for ailments beyond diabetes and its natural agonism.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190527115538
Personalized Peptide-based vaccination for treatment of colorectal cancer: rational and progress.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190619121658
Vedolizumab in the perioperative management of inflammatory bowel disease.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190325130142
Innovative Methodology in the Discovery of Novel Drug Targets in the Free-Living Amoebae.
来源期刊：Current drug targetsDOI：10.2174/1389450119666180426100452
Photopolymerizable Resins for 3D-Printing Solid-Cured Tissue Engineered Implants.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190114122815
Natural aldose reductase inhibitor: A potential therapeutic agent for non-alcoholic fatty liver disease.
来源期刊：Current drug targetsDOI：10.2174/1389450120666191007111712
Targeting strategies in therapeutic applications of Toxoplasmosis; Recent advances in liposomal vaccine delivery systems.
来源期刊：Current drug targetsDOI：10.2174/1389450120666191023151423
Snake Venom Disintegrins: An Overview of their Interaction with Integrins.
来源期刊：Current drug targetsDOI：10.2174/1389450119666181022154737
Nano Drug Delivery in Treatment of Oral Cancer, A Review of the Literature.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190319125734
Absolute blood eosinophil counts to guide inhaled corticosteroids therapy among patients with COPD, GOLD 2019: Systematic review and meta-analysis of evidence.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190808141625
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma.
来源期刊：Current drug targetsDOI：10.2174/1389450120666191017113051
Aryl Hydrocarbon Receptor: Its Regulation and Roles in Transformation and Tumorigenesis.
来源期刊：Current drug targetsDOI：10.2174/1389450120666181109092225
Age-related macular degeneration: current knowledge of zinc metalloproteinases involvement.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190122114857
Structural and Mechanistic Insights of CRAC Channel as a Drug Target in Autoimmune Disorder.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190926150258
Understanding the pharmaceutical aspects of dendrimers for the delivery of anticancer drugs.
来源期刊：Current drug targetsDOI：10.2174/1389450120666191031092259
The Value of Biomarkers in Optimizing the Use of Immuno-oncologic Therapy.
来源期刊：Current drug targetsDOI：10.2174/1389450119666180911093143
Ferula hermonis: a review of current use and pharmacological studies of its sesquiterpene ester ferutinin.
来源期刊：Current drug targetsDOI：10.2174/1389450120666191029155053
A Multi-perspective Review of Dengue Research.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190724145937
Flavonoid-derived privileged scaffolds in anti-Trypanosoma brucei drug discovery.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190618114857
Current drug nano-targeting strategies for improvement in the diagnosis and treatment of prevalent pathologies such as cardiovascular and renal diseases.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190702162533
Potential Applications of Induced Pluripotent Stem Cells for Cardiovascular Diseases.
来源期刊：Current drug targetsDOI：10.2174/1389450120666181211164147
Plant Derived Natural Alkaloids as New Antimicrobial and Adjuvant Agents in Existing Antimicrobial Therapy.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190618124224
CD28: A new drug target for immune disease.
来源期刊：Current drug targetsDOI：10.2174/1389450120666191114102830
Does Vitamin K Intake Influence High Phosphate Induced Vascular Pseudo-ossification: An Underappreciated Therapeutic Prospect in General Population?
来源期刊：Current drug targetsDOI：10.2174/1389450119666181031124430
The Role of Reactive Oxygen Species in Tumor Treatment and its Impact on Bone Marrow Hematopoiesis.
来源期刊：Current drug targetsDOI：10.2174/1389450120666191021110208
Subduing the Green-eyed Monster: Bridging the Psychopharmacological and Psychosocial Treatment Perspective in Understanding Pathological Jealousy.
来源期刊：Current drug targetsDOI：10.2174/1389450118666170704142708
Natural occurring compounds inhibit osteoclastogenesis via targeting on NFATc1-related signaling pathways.
来源期刊：Current drug targetsDOI：10.2174/1389450120666191017121610
Study of Intercellular Adhesion Molecule-1 (ICAM-1) on Bone Homeostasis.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190927122553
Potential Non-neoplastic Applications for Polyphenols in Stem Cell Utilization.
来源期刊：Current drug targetsDOI：10.2174/1389450119666180731092453
NOB1: A potential biomarker or target in cancer.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190308145346
Computational Approaches for Elucidating Protein-Protein Interactions in Cation Channel Signaling.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190906154412
Considering circadian pattern of blood pressure in treatment of hypertension via chronotherapy: A conducive or a maladroit approach.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190527114529
Plasminogen Receptors in Human Malignancies: Effects on Prognosis and Feasibility as Targets for Drug Development.
来源期刊：Current drug targetsDOI：10.2174/1389450120666191122101658
Structure and function of proprotein convertase subtilisin/kexin type 9 (PCSK9) in atherosclerosis.
来源期刊：Current drug targetsDOI：10.2174/1389450120666190214141626

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACSMS HEALTH & FITNESS JOURNAL封面

ACSMS HEALTH & FITNESS JOURNAL

学科领域：医学
影响因子：1.8
中科院分区： 4区
ACTA BIOQUIMICA CLINICA LATINOAMERICANA封面

ACTA BIOQUIMICA CLINICA LATINOAMERICANA

学科领域：医学
影响因子：0.1
中科院分区： 4区
Acta Cardiologica Sinica封面

Acta Cardiologica Sinica

学科领域：医学
影响因子：1.8
中科院分区： 4区
Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca封面

Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca

学科领域：医学
影响因子：0.4
中科院分区： 4区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
否
是
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
否
是